The focus of the current study was to increase the knowledge on the relationship between alteration on rpL3 levels induced by nucleolar stress and activity of 5-FU for the treatment of the colon cancers laking p53; the full understanding of p53-independent pathways implicated in colon cancer molecular biology may provide new targets for cancer therapy. The gene discussed is TP53; the disease is colonic neoplasm.